← All companies
N
NewAmsterdam Pharma Company N.V.
NAMS
Market cap$4.16 B
Rank#1563
Filings386
NewAmsterdam Pharma Company N.V. has filed 386 public company documents between 2022 and 2026. The most frequent type is insider trade (101 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Continue researchNAMS overview$4.16 BMarket cap, financials, charts, and latest company context.
Continue researchMarket cap historyRank #1563See the market value trend behind the filing history.
Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.
Continue researchCompare with LLYPeer viewPut NAMS beside LLY across market cap, revenue, income, and filings.
Similar companies to research next
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.